Bixiye
QP10-24 Commercial and MHCP Pharmacy Benefit Exclusion for Casgevy™, iDose® TR, and Lyfgenia™
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1631 - 1640 ee natiijooyinka 3289
Bixiye
QP6R1-24 Full-Service Product Expansion
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
QP9-24 Individual Affiliation Requirements for Personal Care Assistance (PCA) Agencies
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
QP12-24 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective March 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
QP14-24 Commercial Pharmacy Benefit Exclusion for Select Medications
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
QP11-24 Commercial Pharmacy Benefit Update: New and Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective April 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
QP15-24 Rural Health Care (RHC) Replacement Claims for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
QP13-24 Providers Must be Enrolled with DHS Prior to Submitting Contract Requests
Taariikhda uu dhaqangalayo Barnaamijka: 14, Feb 2024
Bixiye
P6-24 Removing 99606 Visit Limitation for Medication Therapy Management (MTM) Services in the Medicaid Population Starting April 1, 2024
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2024
Bixiye
P7-24 eviCore Healthcare Specialty Utilization Management (UM) Program: Cardiology and Radiology Clinical Guideline Updates
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2024